Place of Origin : Shang Hai,China
• High purity, low endotoxin. Potassium sucrose heptasulfate / potassium sucrose octasulfate <0.1%.
• CDE registration number: F20210000349, US DMF under prepration.
• Better novel excipient for active drug loading in liposomes, Avoid hydrolysis and inactivation of irinotecan lactone ring, improve drug stability and prolong half-life.
• High Purity, Low Endotoxin. Potassium Sucrose Heptasulfate / potassium Sucrose Octasulfate <0.1%.
• CDE Registration Number: F20210000349, US DMF Under Prepration.
• Better Novel Excipient For Active Drug Loading In Liposomes, Avoid Hydrolysis And Inactivation Of Irinotecan Lactone Ring, Improve Drug Stability And Prolong Half-life.
AVT, Being One Of The Leading pharmaceutical Excipients Manufacturers, Has Been Cultivating The Market Of High-end Complex Injection In China For More Than Ten Years.
AVT Provides High-quality Pharma Excipients, such As excipients Used In Injections .